All Stories

  1. Cytokine “storm”, cytokine “breeze”, or both in COVID-19?
  2. Mario Plebani turns 70
  3. Making sense of rapid antigen testing in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnostics
  4. IFCC Interim Guidelines on Molecular Testing of SARS-CoV-2 Infection
  5. Upper respiratory samples pooling for screening SARS-CoV-2 infection: ready for the prime time?
  6. Validation of the Corona-Score for rapid identification of SARS-CoV-2 infections in patients seeking emergency department care in the United States
  7. Preliminary evaluation of Roche Cobas Elecsys Anti-SARS-CoV-2 chemiluminescence immunoassay
  8. Asymptomatic COVID-19 transmission: the importance of avoiding official miscommunication
  9. Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?
  10. Headache is an important symptom in patients with coronavirus disease 2019 (COVID-19)
  11. Biosafety measures for preventing infection from COVID-19 in clinical laboratories: IFCC Taskforce Recommendations
  12. Assessment of immune response to SARS-CoV-2 with fully automated MAGLUMI 2019-nCoV IgG and IgM chemiluminescence immunoassays
  13. Identifying clinical predictors of severe and fatal forms of COVID-19
  14. Mean platelet volume in arterial and venous thrombotic disorders
  15. Reversing the adverse health effects of prolonged lockdowns
  16. PREDICT: a checklist for preventing preanalytical diagnostic errors in clinical trials
  17. The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks
  18. Reviewing potential vulnerabilities in COVID-19 diagnostics
  19. Laboratory abnormalities in diagnostic tests for Covid-19 infection
  20. A modern and pragmatic definition of Laboratory Medicine
  21. Further advices on measuring lipoprotein(a) for reducing the residual cardiovascular risk on statin therapy
  22. The “olfactory fingerprint”: can diagnostics be improved by combining canine and digital noses?
  23. The novel coronavirus (2019-nCoV) outbreak: think the unthinkable and be prepared to face the challenge
  24. Are icteric and lipemic indices reliable to screen for hyperbilirubinemia and hypertriglyceridemia?
  25. Two-center comparison of 10 fully-automated commercial procalcitonin (PCT) immunoassays
  26. Predicting mortality with cardiac troponins: recent insights from meta-analyses
  27. Managing hemolyzed samples in clinical laboratories
  28. An unusual case of sodium citrate-dependent artifactual platelet count
  29. Sepsis biomarkers: past, present and future
  30. The Model List of Essential In Vitro Diagnostics: nuisance or opportunity?
  31. Understanding the “philosophy” of laboratory hemostasis
  32. Routine coagulation testing in Vacutainer® Citrate Plus tubes filled at minimum or optimal volume
  33. Kiwifruit and Cancer: An Overview of Biological Evidence
  34. Red blood cell distribution width predicts 1-month complications after percutaneous transluminal angioplasty
  35. Project management in laboratory medicine
  36. Exertional hematuria: definition, epidemiology, diagnostic and clinical considerations
  37. Identification and management of spurious hemolysis: controversies, concerns and criticisms
  38. Can citrate plasma be used in exceptional circumstances for some clinical chemistry and immunochemistry tests?
  39. Filling accuracy of sodium citrate test tubes
  40. Influence of hypertriglyceridemia, hyperbilirubinemia and hemolysis on thrombin generation in human plasma
  41. Cost, profitability and value of laboratory diagnostics: in God we trust, all others bring data
  42. Public perception of diagnostic and laboratory errors among Internet users
  43. Advantages and limitations of total laboratory automation: a personal overview
  44. Preanalytical challenges – time for solutions
  45. Impact of blood cell counts and volumes on glucose concentration in uncentrifuged serum and lithium-heparin blood tubes
  46. Willingness-to-pay threshold for preventing spurious hemolysis during blood sample collection
  47. Glucose variation in centrifuged serum and lithium-heparin gel tubes stored for up to 96 hours at room temperature or 4 °C
  48. D-dimer: Preanalytical, analytical, postanalytical variables, and clinical applications
  49. PSA-based, prostate cancer risk on-line calculators: no such thing as a crystal ball?
  50. Diabetes alert dogs: a narrative critical overview
  51. Values and stability of serum (or plasma) indices in uncentrifuged serum and lithium-heparin plasma
  52. Diagnostic biomarkers of muscle injury and exertional rhabdomyolysis
  53. Proteomics and frailty: a clinical overview
  54. Clinical Chemistry and Laboratory Medicine continues to shine brightly in the constellation of laboratory medicine
  55. The preanalytical phase in the era of high-throughput genetic testing. What the future holds
  56. Laboratory hemostasis: from biology to the bench
  57. Is the hemolysis index always suitable for monitoring phlebotomy performance?
  58. Interruptions, work environment and work load perceptions in laboratory medicine: patient safety is a “moving target”
  59. Weighting healthcare efficiency against available resources: value is the goal
  60. Blood sample quality
  61. Procalcitonin for diagnosing and monitoring bacterial infections: for or against?
  62. Scientific publishing in the “predatory” era
  63. Preanalytical errors before and after implementation of an automatic blood tube labeling system in two outpatient phlebotomy centers
  64. Harmonization of laboratory hematology: a long and winding journey
  65. Polyphenols: Potential Use in the Prevention and Treatment of Cardiovascular Diseases
  66. Practical recommendations for managing hemolyzed samples in clinical chemistry testing
  67. Diagnosis is now indexed in PubMed
  68. Modulation of Heart Rate by Acute or Chronic Aerobic Exercise. Potential Effects on Blood Pressure Control
  69. Visual assessment of sample quality: quo usque tandem?
  70. Challenges and Opportunities in Implementing Total Laboratory Automation
  71. Hyponatremia and Bone Fractures: An Intriguing and often Overlooked Association
  72. Syncope: current knowledge, uncertainties and strategies for management optimisation in the emergency department
  73. The risk of unjustified BRCA testing after the “Angelina Jolie effect”: how can we save (laboratory) medicine from the Internet?
  74. Reporting altered test results in hemolyzed samples: is the cure worse than the disease?
  75. Analytical evaluation of the new Beckman Coulter Access high sensitivity cardiac troponin I immunoassay
  76. The EFLM strategy for harmonization of the preanalytical phase
  77. Laboratory testing in the emergency department: an Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC) and Academy of Emergency Medicine and Care (AcEMC) consensus report
  78. Novel Opportunities for Improving the Quality of Preanalytical Phase. A Glimpse to the Future?
  79. Exploring the iceberg of inappropriateness in hemostasis testing
  80. The Role of Red Blood Cell Distribution Width for Predicting 1-year Mortality in Patients Admitted to the Emergency Department with Severe Dyspnoea
  81. Innovative software for recording preanalytical errors in accord with the IFCC quality indicators
  82. Improving quality in the preanalytical phase through innovation, on behalf of the European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for Preanalytical Phase (WG-PRE)
  83. Patient and Sample Identification. Out of the Maze?
  84. Estimating the intra- and inter-individual imprecision of manual pipetting
  85. Opportunities and drawbacks of nonstandard body fluid analysis
  86. The serum concentrations of leptin and MCP-1 independently predict low back pain duration
  87. Evidence for the Involvement of Lipid Rafts and Plasma Membrane Sphingolipid Hydrolases in Pseudomonas aeruginosa Infection of Cystic Fibrosis Bronchial Epithelial Cells
  88. Analytical imprecision of lactate dehydrogenase in primary serum tubes
  89. The Mean Platelet Volume Is Decreased in Patients Diagnosed with Venous Thromboembolism in the Emergency Department
  90. Factor XII in Hemostasis and Thrombosis: Active Player or (Innocent) Bystander?
  91. Diagnostics of Inherited Bleeding Disorders of Secondary Hemostasis: An Easy Guide for Routine Clinical Laboratories
  92. Cardiac troponins and mortality in type 1 and 2 myocardial infarction
  93. Capillary electrophoresis for the screening and diagnosis of inherited hemoglobin disorders. Ready for prime time?
  94. Building a bridge to safe diagnosis in health care. The role of the clinical laboratory
  95. Birth season predicts the values of red blood cell distribution width (RDW) in adulthood
  96. Macroprolactin: searching for a needle in a haystack?
  97. Protein S100B: from cancer diagnostics to the evaluation of mild traumatic brain injury
  98. Low serum bilirubin values are associated with pulmonary embolism in a case-control study
  99. Mobile phone exposure influences some erythrocytes parameters in vitro. A novel source of preanalytical variability?
  100. Assessment of reticulated platelets with automated hemocytometers: are we measuring the same thing?
  101. Cardiac Troponin I Is Increased in Patients with Polytrauma and Chest or Head Trauma. Results of A Retrospective Case-Control Study
  102. Comparison of the novel Maglumi ferritin immunoluminometric assay with Beckman Coulter DxI 800 ferritin
  103. Serum myoglobin immunoassays: obsolete or still clinically useful?
  104. Laboratory economics. Risk or opportunity?
  105. Access to scientific information. A national survey of the Italian Society of Clinical Biochemistry and Laboratory Medicine (SIBioC)
  106. Allergy and Venous Thromboembolism: A Casual or Causative Association
  107. Fish Intake and Venous Thromboembolism
  108. What Do Hemolyzed Whole-Blood Specimens Look Like? Analysis with a CellaVision DM96 Automated Image Analysis System
  109. Reflections on the next generation of hemostasis instrumentation. A glimpse into the future?
  110. Laboratory biomarkers and frailty: presentation of the FRAILOMIC initiative
  111. Comparison of nucleated red blood cell count with four commercial hematological analyzers
  112. Laboratory medicine does matter in science (and medicine)… yet many seem to ignore it
  113. Cell-free DNA for diagnosing myocardial infarction: not ready for prime time
  114. Adjustment of serum potassium for age and platelet count. A simple step forward towards personalized medicine
  115. Analytical assessment of the novel homocysteine liquid enzymatic assay on Beckman Coulter AU5800
  116. Biomarkers of inflammatory bowel disease: ready for prime time?
  117. The baseline serum value of α-amylase is a significant predictor of distance running performance
  118. Preanalytical quality improvement. In pursuit of harmony, on behalf of European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working group for Preanalytical Phase (WG-PRE)
  119. Analytical evaluation of Diazyme procalcitonin (PCT) latex-enhanced immunoturbidimetric assay on Beckman Coulter AU5800
  120. Ranking prestige of medical and laboratory technology journals
  121. Personalized medicine: moving from simple theory to daily practice
  122. A case of factitious hyponatremia and hypokalemia due to the presence of fibrin gel in serum
  123. Check-in and Sorting of Centrifuged Serum and Lithium-Heparin Tubes May Be Unsuitable Using a Bulk Input Module
  124. Influence of hemolysis on troponin testing: studies on Beckman Coulter UniCel Dxl 800 Accu-TnI and overview of the literature